Literature DB >> 7525933

Substance P activates rat colonic motility via excitatory and inhibitory neural pathways and direct action on muscles.

U Scheurer1, E Drack, F Halter.   

Abstract

We studied effects of nicotinic, muscarinic, serotoninergic, dopaminergic, adrenergic, vasoactive intestinal peptide (VIP) antagonists, VIP, nitric oxide-synthase inhibitors and stimulators alone and in combination with tetrodotoxin on substance P (SP)-stimulated intraluminal tone of the isolated proximal, middle and distal rat colon. Tetrodotoxin significantly enhanced SP-stimulated intraluminal tonic pressure in the distal, but not in the middle and proximal colon. N omega-nitro-L-arginine methylester enhanced SP stimulation in all colonic segments, whereas L-arginine inhibited it partially and D-arginine did not affect it. Atropine and hexamethonium partially inhibited SP stimulation of the middle and distal colon. Tetrodotoxin completely abolished the effects of L-arginine, atropine and/or hexamethonium on SP stimulation. Propranolol, phentolamine, reserpine, telenzepine, naloxone, Mr 2266, a VIP antagonist (H9935) and ketanserin did not affect SP-induced colonic muscle stimulation. VIP strongly reduced SP-stimulated intraluminal pressure in all colonic segments. VIP(10-28), a putative VIP antagonist, produced similar inhibition of SP-stimulated intraluminal tonic pressure, but did not affect N omega-nitro-L-arginine methylester-induced enhancement of SP-stimulated intraluminal pressure in any segments. It is concluded that in the isolated rat colon SP-stimulated intraluminal pressure (mainly generated by circular muscles) by a direct action on colonic muscles over the whole colonic length and by simultaneous activation of neural cholinergic excitatory pathways in the middle and distal, of noncholinergic excitatory pathways in the proximal colonic segment, and by activation of nitric oxide-dependent inhibitory neural pathways. VIP seems not to be directly involved in this inhibitory pathway.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7525933

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  4 in total

1.  Neural contractions in colonic strips from patients with diverticular disease: role of endocannabinoids and substance P.

Authors:  F Guagnini; M Valenti; S Mukenge; I Matias; A Bianchetti; S Di Palo; G Ferla; V Di Marzo; T Croci
Journal:  Gut       Date:  2006-01-19       Impact factor: 23.059

2.  Increase in neurokinin-1 receptor-mediated colonic motor response in a rat model of irritable bowel syndrome.

Authors:  Jun-Ho La; Tae-Wan Kim; Tae-Sik Sung; Hyn-Ju Kim; Jeom-Yong Kim; Il-Suk Yang
Journal:  World J Gastroenterol       Date:  2005-01-14       Impact factor: 5.742

3.  Neurochemical phenotype and function of endomorphin 2-immunopositive neurons in the myenteric plexus of the rat colon.

Authors:  Jun-Ping Li; Xi-Yu Wang; Chang-Jun Gao; Yong-Hui Liao; Juan Qu; Zhong-Yi He; Ting Zhang; Guo-Du Wang; Yun-Qing Li
Journal:  Front Neuroanat       Date:  2014-12-16       Impact factor: 3.856

4.  Nanocrystalline cerium dioxide efficacy for gastrointestinal motility: potential for prokinetic treatment and prevention in elderly.

Authors:  Olena Yu Yefimenko; Yuliya O Savchenko; Tetyana M Falalyeyeva; Tetyana V Beregova; Nadiya M Zholobak; Mykola Ya Spivak; Oleksandr B Shcherbakov; Rostyslav V Bubnov
Journal:  EPMA J       Date:  2015-03-11       Impact factor: 6.543

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.